4me and Vitality Unveil the Future of Autonomous Enterprise Service Management at SITS24
In an era where digital transformation is more than just a buzzword, the SITS24 conference stands as a beacon for IT Service Management and Support professionals seeking to harness innovative technologies and ideas to propel their IT and enterprise service delivery. Scheduled for April 17-18, 2024 at the ExCeL conference center in London, SITS24 is a powerful opportunity to dive into current industry trends and explore the future.
SITS24 is a unique confluence of innovation, knowledge-sharing and community engagement, and also a forum for all attendees to meaningfully connect with each other and contribute to thought-leadership in the industry. As part of that mission, 4me®, the SaaS-based Service Management software platform for the modern enterprise, is delighted to announce that leading industry figures, Martijn Adams of 4me, and Anthony Cook of Vitality, will be hosting a session titled “Autonomous Enterprise Service Management.”
Martijn Adams and Anthony Cook: Visionaries at the Helm
As leaders in IT and service management, Martijn Adams and Anthony Cook bring a wealth of experience and insights to SITS24. Their session will delve into methods by which IT, HR, Finance and other enterprise functions can thrive with fewer resources, while simultaneously enhancing the quality and efficiency of the support they offer.
Empowering the Future of Enterprise Service Management
In a landscape defined by the relentless pace of technological evolution and a tight labor market, our distinguished speakers will explore the transformative potential of AI and automation in service management. This session, scheduled for April 17, 2024, from 10:00 to 11:00, is designed as a practical roadmap for enterprises aspiring to elevate their service management platforms to new heights of autonomy and efficiency.
Secure Your Spot
Don’t miss this opportunity to be part of a defining moment in the ITSM industry. Attend the session, visit 4me at Booth #520, and get excited about what’s in store for the future of service management. Together, let’s celebrate innovation, share knowledge, and build a stronger ITSM community. For more details, visit https://www.servicedeskshow.com/.
About 4me, Inc.
4me is transforming service management for the modern enterprise. 4me’s AI-forward, service-oriented, multi-tenant SaaS platform seamlessly connects teams to optimize IT service management. 4me’s ability to automate cross-functional workflows makes frictionless service delivery possible, significantly improving business outcomes. The 4me platform’s ease of use and deployment makes it the most advanced ITSM platform available today. Hundreds of organizations around the world look to 4me to elevate their Enterprise Service Management. To learn more, visit www.4me.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240417194134/en/
Contact information
Media Contact:
David Libby
2pinz
415-518-6611
david@2pinz.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Logitech Announces Q4 and Full Fiscal Year 2024 Results30.4.2024 04:01:00 EEST | Press release
SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2024 ended March 31, 2024. For Q4 Fiscal Year 2024: Sales were $1.01 billion, up 5 percent in US dollars and 5 percent in constant currency, compared to Q4 of the prior year. GAAP operating income was $130 million, up 235 percent, compared to Q4 of the prior year. Non-GAAP operating income was $159 million, up 93 percent, compared to Q4 of the prior year. GAAP earnings per share (EPS) was $1.07, up 312 percent compared to Q4 prior year. Non-GAAP EPS was $0.99, up 98 percent compared to the prior year. Cash flow from operations was $239 million, up 10 percent compared to Q4 of the prior year. For Fiscal Year 2024: Sales were $4.30 billion, down 5 percent in US dollars and 6 percent in constant currency, compared to the prior year. GAAP operating income was $587 million, up 28 percent compared to th
WEF Special Meeting Concludes in Riyadh With World Leaders Calling for Clear, Irreversible Path to Peace and Prosperity as Top Global Priority30.4.2024 00:02:00 EEST | Press release
Riyadh hosted more than 1,000 global leaders for the two-day World Economic Forum (WEF) Special Meeting in Riyadh, where leading political, economics, energy and technology figures called for clear pathways to stability, prosperity and inclusive growth opportunities in the face of rising cross-border challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240429767765/en/ Saudi Minister of Economy and Planning His Excellency Faisal Alibrahim announces Saudi Arabia will join the AI Governance Alliance to co-launch the ‘Inclusive AI Initiative for Growth and Development’ (Photo: AETOSWire) The more than 1,000 participants in for the WEF Special Meeting on Global Collaboration, Growth and Energy for Development made it the highest-ever number of registrations for a WEF event hosted outside of its Annual Meeting venue in Davos Klosters, Switzerland. The Special Meeting set the stage for the launch of several initiatives in th
CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology30.4.2024 00:00:00 EEST | Press release
Please replace the release dated April 26, 2024 with the following corrected version due to multiple revisions. The updated release reads: RENAGADE THERAPEUTICS CONTINUES COMMITMENT TO GANNA BIO AND GLYCAN BIOLOGY GanNA founders include Carolyn Bertozzi, Ph.D., Richard D. Cummings, Ph.D., Ryan A. Flynn, M.D., Ph.D., and Namita Bisaria, Ph.D., M.B.A. Additional investment strengthens ReNAgade’s delivery platform with unique conjugation platform based on novel glycobiology ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to unlock the potential of glycobiology through support for ongoing research at GanNA Bio, and an integration of the key founders of GanNA Bio into the ReNAgade ecosystem. GanNA Bio was formed in 2021 and invested in by ReNAgade to harness novel glycobiology to enable extra-hepatic RNA delivery based on pioneering research licensed from Stanford University, Boston Children’s Hospital, and Beth Is
Sun Nuclear Announces Landmark Update to Further Advance Radiation Therapy Workflows29.4.2024 23:30:00 EEST | Press release
Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK® software for comprehensive Quality Management in radiation therapy. The SunCHECK software is used globally by radiation therapy departments to manage delivery system oversight and patient-specific treatment quality --- all in one platform. SunCHECK Version 5.0 introduces a broad range of features and user-driven enhancements that optimize workflows and prioritize patient safety. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240429991805/en/ Sun Nuclear, a Mirion Medical company, announced the upcoming version 5.0 release of its SunCHECK® software for comprehensive Quality Management in radiation therapy. SunCHECK v5.0 addresses clinical workflow challenges with new treatment plan assessment capabilities, enhanced TPS/OIS integration, expanded QA device control, and worklist-based UI. (Graphic: Business Wire) The Connecte
Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company29.4.2024 23:05:00 EEST | Press release
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital and other customary closing adjustments. “Endomag’s suite of solutions complements our existing breast surgery portfolio and will provide surgeons and radiologists with an expanded range of options to meet the individual needs of more patients undergoing critical breast cancer procedures,” said Erik Anderson, President of Breast and Skeletal Health Solutions at Hologic. “With a global footprint and a similar commitment to women’s health, we are excited about the potential of welcoming the Endomag team and our future opportunities together to increase access to these technologies and better serve patients across the breast health continuum of care.” Endomag, which is based in Cambridge, United Kingdom, deve
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom